Study of the Effects of Oral AT1001 (Migalastat Hydrochloride) in Patients With Fabry Disease

NCT00925301 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

67

Enrollment

INDUSTRY

Sponsor class

Conditions

Fabry Disease

Interventions

DRUG: migalastat hydrochloride
DRUG: Placebo

Sponsor

Amicus Therapeutics